secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2022-10-12T23:59:59+00:00
Accession:  0001493152-22-028260
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma shareholders vote to reduce authorized common stock from 750M to 250M shares
--------------------------------------------------------------------------------

- Special meeting held Oct 10, 2022; 17,442,945 of 31,092,498 shares represented (56.1%).
- Proposal to ratify amendment reducing authorized common stock from 750M to 250M shares passed.
- Vote: 17,201,108 For, 227,621 Against, 14,216 Abstain.
- The amendment was previously proposed at the 2022 Annual Meeting as Proposal No. 4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315222028260/0001493152-22-028260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315222028260/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-028260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer